Literature DB >> 9544573

Nonspecific and immune-specific up-regulation of cytokines in rabbit dermal tuberculous (BCG) lesions.

K Sugisaki1, A M Dannenberg, Y Abe, J Tsuruta, W J Su, W Said, L Feng, T Yoshimura, P J Converse, P Mounts.   

Abstract

To our knowledge, this is the first sequential study of cytokines in tissue sections of developing and healing tuberculous (BCG) lesions. In situ hybridization, immunohistochemical, and RT-PCR techniques were used. Cytokine mRNAs showed a biphasic pattern. The percentage of mononuclear cells (MN) containing IL-1beta, TNF-alpha, MCP-1, and IL-8 mRNAs was highest in 1- to 3-day lesions, apparently because of the nonspecific inflammatory response caused by the tubercle bacilli in the BCG vaccine. At 5 days, this percentage was significantly reduced. With IFN-gamma, the peak and trough were delayed by 2 days. By 9 days, the percentage of MN containing the mRNAs of all five cytokines had again increased and the rabbits had become tuberculin-positive. In general, MCP-1 and TNF-alpha proteins and the vascular adhesion molecules, ICAM, VCAM, and perhaps ELAM, peaked at about 3 days. Many mononuclear cells surrounding the central areas of solid and liquefied caseous necrosis contained chemokine IL-8 mRNA. IL-8 is known to attract PMN, and PMN were present nearby. In contrast, MN containing chemokine MCP-1 mRNA were present more peripherally in areas rich in macrophages and lymphocytes. The early nonspecific cytokine response seems to be an adjuvant effect of the mycobacteria in BCG vaccine in that it causes a rapid entry of macrophages, lymphocytes, granulocytes, and probably dendritic cells into local sites of antigen deposition. This effect should be considered in developing improved vaccines for the prevention of tuberculosis, because BCG vaccines producing a strong early cytokine response should be more immunogenic than BCG vaccines with similar antigens producing a weak response.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9544573     DOI: 10.1002/jlb.63.4.440

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  9 in total

Review 1.  Role of chemokines in inflammation and immunoregulation.

Authors:  L Feng
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

2.  Immune responses in tuberculosis: antibodies and CD4-CD8 lymphocytes with vascular adhesion molecules and cytokines (chemokines) cause a rapid antigen-specific cell infiltration at sites of bacillus Calmette-Guérin reinfection.

Authors:  T Shigenaga; A M Dannenberg; D B Lowrie; W Said; M J Urist; H Abbey; B H Schofield; P Mounts; K Sugisaki
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

3.  Evaluation of mycobacterial virulence using rabbit skin liquefaction model.

Authors:  Guoping Zhang; Bingdong Zhu; Wanliang Shi; Mingzhu Wang; Zejiao Da; Ying Zhang
Journal:  Virulence       Date:  2010 May-Jun       Impact factor: 5.882

4.  BCG-induced rabbit alveolar macrophages are endowed with strengthened antioxidant metabolic pathways.

Authors:  Francesca Vita; Rita Abbate; Violetta Borelli; Cristiana Brochetta; Maria Rosa Soranzo; Giuliano Zabucchi
Journal:  Inflammation       Date:  2007-10-02       Impact factor: 4.092

5.  A human challenge model for Mycobacterium tuberculosis using Mycobacterium bovis bacille Calmette-Guerin.

Authors:  Angela M Minassian; Iman Satti; Ian D Poulton; Joel Meyer; Adrian V S Hill; Helen McShane
Journal:  J Infect Dis       Date:  2012-04-01       Impact factor: 7.759

6.  Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis.

Authors:  R J Wilkinson; P Patel; M Llewelyn; C S Hirsch; G Pasvol; G Snounou; R N Davidson; Z Toossi
Journal:  J Exp Med       Date:  1999-06-21       Impact factor: 14.307

7.  IL-1RN and IL-1β Polymorphism and ARV-Associated Hepatotoxicity.

Authors:  HariOm Singh; Dharmesh Samani; Vijay Nema; Manisha V Ghate; R R Gangakhedkar
Journal:  Mediators Inflamm       Date:  2018-04-08       Impact factor: 4.711

Review 8.  What Have We Learnt about BCG Vaccination in the Last 20 Years?

Authors:  Hazel M Dockrell; Steven G Smith
Journal:  Front Immunol       Date:  2017-09-13       Impact factor: 7.561

Review 9.  Progressive Host-Directed Strategies to Potentiate BCG Vaccination Against Tuberculosis.

Authors:  Kriti Negi; Ashima Bhaskar; Ved Prakash Dwivedi
Journal:  Front Immunol       Date:  2022-07-28       Impact factor: 8.786

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.